Head-to-head intra-individual comparison of biodistribution and tumor uptake of (18F)FAPI-74 with (18F)FDG in patients with PDAC: a prospective exploratory study
Background: Radiolabeled fibroblast activation protein (FAP) ligands, a novel class of tracers for PET/CT imaging, have demonstrated very promising results in various oncological, as well as in some benign, diseases with long-term potential to supplant the current pan-cancer agent [18F]FDG in some c...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2023
|
| In: |
Cancers
Year: 2023, Jahrgang: 15, Heft: 10, Pages: 1-13 |
| ISSN: | 2072-6694 |
| DOI: | 10.3390/cancers15102798 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.3390/cancers15102798 Verlag, kostenfrei, Volltext: https://www.mdpi.com/2072-6694/15/10/2798 |
| Verfasserangaben: | Emil Novruzov, Frederik L. Giesel, Yuriko Mori, Peter L. Choyke, Mardjan Dabir, Eduards Mamlins, Dominik Schmitt, Christina Antke, Claudio Pinto, Cristian Soza-Ried, Rene Fernandez, Horacio Amaral, Vasko Kramer and Leonardo Badinez |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1853646164 | ||
| 003 | DE-627 | ||
| 005 | 20240307065100.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230726s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3390/cancers15102798 |2 doi | |
| 035 | |a (DE-627)1853646164 | ||
| 035 | |a (DE-599)KXP1853646164 | ||
| 035 | |a (OCoLC)1425214305 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Novruzov, Emil |d 1988- |e VerfasserIn |0 (DE-588)1228349223 |0 (DE-627)1750106647 |4 aut | |
| 245 | 1 | 0 | |a Head-to-head intra-individual comparison of biodistribution and tumor uptake of (18F)FAPI-74 with (18F)FDG in patients with PDAC |b a prospective exploratory study |c Emil Novruzov, Frederik L. Giesel, Yuriko Mori, Peter L. Choyke, Mardjan Dabir, Eduards Mamlins, Dominik Schmitt, Christina Antke, Claudio Pinto, Cristian Soza-Ried, Rene Fernandez, Horacio Amaral, Vasko Kramer and Leonardo Badinez |
| 246 | 3 | 3 | |a Head-to-head intra-individual comparison of biodistribution and tumor uptake of (18 F)FAPI-74 with (18 F)FDG in patients with PDAC |
| 264 | 1 | |c 2023 | |
| 300 | |a 13 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Veröffentlicht: 17. Mai 2023 | ||
| 500 | |a Gesehen am 26.07.2023 | ||
| 500 | |a Im Titel ist der Ausdruck "18F" eckig geklammert und die Zahl 18 hochgestellt | ||
| 520 | |a Background: Radiolabeled fibroblast activation protein (FAP) ligands, a novel class of tracers for PET/CT imaging, have demonstrated very promising results in various oncological, as well as in some benign, diseases with long-term potential to supplant the current pan-cancer agent [18F]FDG in some cancer types. Pancreatic ductal carcinoma (PDAC) belongs to the group of epithelial malignancies with a strong so-called “desmoplastic reaction”, leading to a prominent tumor stroma with cancer-associated fibroblasts that exhibit a marked overexpression of fibroblast activation protein (FAP). The first clinical experiences in PDAC with 68Ga-labeled FAP ligands suggested superior sensitivity to [18F]FDG. However, there is limited data with 18F-labeled FAP derivatives, i.e. [18F]FAPI-74, yet prospective single- and multicenter trials are already ongoing. In this proof-of-concept study, we sought to evaluate the biodistribution, tumor uptake, and lesion detectability in patients with PDAC using [18F]FAPI-74 PET/CT as compared to [18F]FDG PET/CT scans for staging. Methods: This study includes 7 patients (median age 69) who underwent both [18F]FDG PET/CT with contrast-enhancement and [18F]FAPI-74 PET with low-dose CT for primary staging (n = 3) and therapy response control after neoadjuvant (n = 1) or re-staging after palliative therapy (n = 3). The mean interval between PET scans was 11 ± 4 days (range 1-15 days). The [18F]FDG and [18F]FAPI-74 PET/CT scans were acquired at 64 ± 4.1 min (range 61-91 min) and 66.4 ± 6.3 min (range 60-76 min), respectively, after administration of 200 ± 94 MBq (range 79-318 MBq) and 235 ± 88 MBq (range 90-321 MBq), respectively. Quantification of tracer uptake was determined with SUVmax and SUVmean. Furthermore, the tumor-to-background ratio (TBR) was derived by dividing the SUVmax of tumor lesions by the SUVmax of adipose tissue, skeletal muscle, and blood pool. Results: Overall, 32 lesions were detected in 7 patients including primary (n = 7), lung (n = 7), bone (n = 3), lymph node (n = 13), and peritoneal metastases (n = 2). [18F]FAPI-74 detected 22% more lesions compared with [18F]FDG with a better TBR and visual lesion delineation. In one patient the primary lesion could be detected unequivocally with [18F]FAPI-74 but was missed by [18F]FDG imaging. Altogether, most of the lesions demonstrated markedly elevated uptake of [18F]FAPI-74 with a simultaneous lower uptake in the background, providing a very high visual contrast. Conclusion: To the best of our knowledge, this is the first, prospective, intra-individual investigation comparing [18F]FAPI-74 with [18F]FDG imaging in PDAC with encouraging results. These pivotalresults supporta larger, multicentric, prospective study to determine the value of [18F]FAPI-74 in detecting and staging PDAC in comparison with current standard of care imaging. | ||
| 650 | 4 | |a FAPI | |
| 650 | 4 | |a FAPI-74 | |
| 650 | 4 | |a FDG | |
| 650 | 4 | |a fibroblast activation protein | |
| 650 | 4 | |a pancreas cancer | |
| 650 | 4 | |a PDAC | |
| 650 | 4 | |a PET | |
| 700 | 1 | |a Giesel, Frederik L. |d 1970- |e VerfasserIn |0 (DE-588)129031240 |0 (DE-627)387883878 |0 (DE-576)297457071 |4 aut | |
| 700 | 1 | |a Mori, Yuriko |e VerfasserIn |4 aut | |
| 700 | 1 | |a Choyke, Peter L. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Dabir, Mardjan |e VerfasserIn |4 aut | |
| 700 | 1 | |a Mamlins, Eduards |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schmitt, Dominik |e VerfasserIn |4 aut | |
| 700 | 1 | |a Antke, Christina |e VerfasserIn |4 aut | |
| 700 | 1 | |a Pinto, Claudio |e VerfasserIn |4 aut | |
| 700 | 1 | |a Soza-Ried, Cristian |e VerfasserIn |4 aut | |
| 700 | 1 | |a Fernandez, Rene |e VerfasserIn |4 aut | |
| 700 | 1 | |a Amaral, Horacio |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kramer, Vasko |e VerfasserIn |4 aut | |
| 700 | 1 | |a Badinez, Leonardo |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cancers |d Basel : MDPI, 2009 |g 15(2023), 10, Artikel-ID 2798, Seite 1-13 |h Online-Ressource |w (DE-627)614095670 |w (DE-600)2527080-1 |w (DE-576)313958548 |x 2072-6694 |7 nnas |a Head-to-head intra-individual comparison of biodistribution and tumor uptake of (18F)FAPI-74 with (18F)FDG in patients with PDAC a prospective exploratory study |
| 773 | 1 | 8 | |g volume:15 |g year:2023 |g number:10 |g elocationid:2798 |g pages:1-13 |g extent:13 |a Head-to-head intra-individual comparison of biodistribution and tumor uptake of (18F)FAPI-74 with (18F)FDG in patients with PDAC a prospective exploratory study |
| 856 | 4 | 0 | |u https://doi.org/10.3390/cancers15102798 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://www.mdpi.com/2072-6694/15/10/2798 |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20230726 | ||
| 993 | |a Article | ||
| 994 | |a 2023 | ||
| 998 | |g 129031240 |a Giesel, Frederik L. |m 129031240:Giesel, Frederik L. |d 910000 |d 911400 |d 50000 |e 910000PG129031240 |e 911400PG129031240 |e 50000PG129031240 |k 0/910000/ |k 1/910000/911400/ |k 0/50000/ |p 2 | ||
| 999 | |a KXP-PPN1853646164 |e 4357830710 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"language":["eng"],"origin":[{"dateIssuedDisp":"2023","dateIssuedKey":"2023"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"physDesc":[{"extent":"13 S."}],"name":{"displayForm":["Emil Novruzov, Frederik L. Giesel, Yuriko Mori, Peter L. Choyke, Mardjan Dabir, Eduards Mamlins, Dominik Schmitt, Christina Antke, Claudio Pinto, Cristian Soza-Ried, Rene Fernandez, Horacio Amaral, Vasko Kramer and Leonardo Badinez"]},"note":["Veröffentlicht: 17. Mai 2023","Gesehen am 26.07.2023","Im Titel ist der Ausdruck \"18F\" eckig geklammert und die Zahl 18 hochgestellt"],"id":{"eki":["1853646164"],"doi":["10.3390/cancers15102798"]},"title":[{"title_sort":"Head-to-head intra-individual comparison of biodistribution and tumor uptake of (18F)FAPI-74 with (18F)FDG in patients with PDAC","title":"Head-to-head intra-individual comparison of biodistribution and tumor uptake of (18F)FAPI-74 with (18F)FDG in patients with PDAC","subtitle":"a prospective exploratory study"}],"relHost":[{"pubHistory":["1.2009 -"],"recId":"614095670","disp":"Head-to-head intra-individual comparison of biodistribution and tumor uptake of (18F)FAPI-74 with (18F)FDG in patients with PDAC a prospective exploratory studyCancers","note":["Gesehen am 27.05.2020"],"title":[{"title_sort":"Cancers","title":"Cancers"}],"id":{"issn":["2072-6694"],"eki":["614095670"],"zdb":["2527080-1"]},"physDesc":[{"extent":"Online-Ressource"}],"name":{"displayForm":["Molecular Diversity Preservation International (MDPI)"]},"part":{"text":"15(2023), 10, Artikel-ID 2798, Seite 1-13","issue":"10","volume":"15","year":"2023","extent":"13","pages":"1-13"},"type":{"bibl":"periodical","media":"Online-Ressource"},"origin":[{"dateIssuedKey":"2009","publisherPlace":"Basel","dateIssuedDisp":"2009-","publisher":"MDPI"}],"language":["eng"]}],"person":[{"given":"Emil","role":"aut","display":"Novruzov, Emil","roleDisplay":"VerfasserIn","family":"Novruzov"},{"role":"aut","display":"Giesel, Frederik L.","given":"Frederik L.","roleDisplay":"VerfasserIn","family":"Giesel"},{"family":"Mori","roleDisplay":"VerfasserIn","role":"aut","display":"Mori, Yuriko","given":"Yuriko"},{"given":"Peter L.","display":"Choyke, Peter L.","role":"aut","roleDisplay":"VerfasserIn","family":"Choyke"},{"roleDisplay":"VerfasserIn","family":"Dabir","given":"Mardjan","display":"Dabir, Mardjan","role":"aut"},{"family":"Mamlins","roleDisplay":"VerfasserIn","given":"Eduards","role":"aut","display":"Mamlins, Eduards"},{"family":"Schmitt","roleDisplay":"VerfasserIn","role":"aut","display":"Schmitt, Dominik","given":"Dominik"},{"role":"aut","display":"Antke, Christina","given":"Christina","family":"Antke","roleDisplay":"VerfasserIn"},{"family":"Pinto","roleDisplay":"VerfasserIn","display":"Pinto, Claudio","role":"aut","given":"Claudio"},{"roleDisplay":"VerfasserIn","family":"Soza-Ried","given":"Cristian","display":"Soza-Ried, Cristian","role":"aut"},{"family":"Fernandez","roleDisplay":"VerfasserIn","role":"aut","display":"Fernandez, Rene","given":"Rene"},{"roleDisplay":"VerfasserIn","family":"Amaral","display":"Amaral, Horacio","role":"aut","given":"Horacio"},{"family":"Kramer","roleDisplay":"VerfasserIn","given":"Vasko","role":"aut","display":"Kramer, Vasko"},{"display":"Badinez, Leonardo","role":"aut","given":"Leonardo","roleDisplay":"VerfasserIn","family":"Badinez"}],"recId":"1853646164","titleAlt":[{"title":"Head-to-head intra-individual comparison of biodistribution and tumor uptake of (18 F)FAPI-74 with (18 F)FDG in patients with PDAC"}]} | ||
| SRT | |a NOVRUZOVEMHEADTOHEAD2023 | ||